-+ 0.00%
-+ 0.00%
-+ 0.00%

Ernexa Therapeutics director David Polinsky files initial beneficial ownership statement

PUBT·08/27/2026 23:53:22
Listen to the news
Ernexa Therapeutics director David Polinsky files initial beneficial ownership statement
  • Director David Polinsky reported 8,000 Ernexa Therapeutics common shares held indirectly through Polo3K, LLC in an initial Form 3 filing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-040466), on August 27, 2026, and is solely responsible for the information contained therein.